AstraZeneca Pharma India Ltd.

NSE: ASTRAZEN | BSE: 506820 | ISIN: INE203A01020 |Industry: Pharmaceuticals
|Expensive Performer
3762.70 -47.50 (-1.25%)
NSE Jan 22, 2021 10:54 AM
Volume: 38,375
 

3762.70
-1.25%
Serum Institute may conduct more tests to get half-dose efficacy
Serum Institute may conduct more tests to get half-dose efficacy
Moneycontrol
Preliminary results on the AstraZeneca vaccine were based on a total of 131 COVID-19 cases in a study involving 11,636 participants.
default
Recommended
More from AstraZeneca Pharma India Ltd.